Job summary
This role involves serving as a scientific liaison across the Nordic region, focusing on breast cancer, precision oncology, and molecular diagnostics. The position entails building and maintaining scientific partnerships with healthcare professionals, facilitating medical education, supporting clinical research, and contributing to medical insights and strategy. The ideal candidate has advanced scientific qualifications and significant experience in oncology-related Medical Affairs roles.
Location and work setup
- Location
- Norway
- Work setup
- Remote
Salary
NOK 876000.00–900000.00 annual
Responsibilities
Develop trusted scientific relationships with breast cancer key opinion leaders and healthcare professionals throughout the Nordic countries. Deliver evidence-based scientific exchange and respond to unsolicited medical queries in compliance with regulations. Present clinical data at scientific and educational events. Support advisory boards and facilitate scientific collaborations aligned with medical objectives. Collect and analyze medical insights to identify unmet needs and emerging trends. Assist in clinical research initiatives including investigator-initiated studies and evidence generation. Collaborate internally with cross-functional teams and provide scientific training. Support planning of congresses and education initiatives.
Qualifications
Advanced scientific degree such as MD, PharmD, PhD, MSc, or equivalent, with at least five years’ experience in Medical Affairs within oncology, molecular diagnostics, biotechnology or pharmaceuticals. Prior Medical Science Liaison experience required, with strong expertise in breast cancer and precision oncology. Familiarity with genomic diagnostics and existing relationships with Nordic breast cancer experts is highly preferred. Strong communication, networking, analytical, and organizational skills are essential, along with the ability to work independently within matrix teams. Willingness to travel extensively (up to 70-75%). Proficiency in Microsoft Office applications is expected.